This site is intended for healthcare professionals
  • Home
  • /
  • Guidelines
  • /
  • Hepatitis
  • /
  • EASL Clinical Practical Guidelines: Management of ...

EASL Clinical Practical Guidelines: Management of Alcoholic Liver Disease

Read time: 1 mins
Last updated:1st Aug 2012

Alcoholic liver disease (ALD) is the most prevalent cause of advanced liver disease in Europe. However, there has been limited research investment into ALD despite its significant burden on the health of Europeans. In recent years however, the mechanisms driving disease progression and the natural history of ALD have been better defined and novel targets for therapy have been identified. In addition, significant clinical research has produced a clear framework for the evaluation of new therapies in particular in patients with alcoholic steatohepatitis (ASH). ALD is a complex disease, the successful management of which hinges on the integration of all the competences in public health, epidemiology, addiction behavior and alcohol-induced organ injury. Both primary intervention to reduce alcohol abuse and secondary intervention to prevent alcohol-associated morbidity and mortality rely on the coordinated action of multidisciplinary teams established at local, national, and international levels.


Read full guideline